NCT07504458
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07504458
Title Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia (QUATRO-APL)
Acronym QUATRO-APL
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Quetzal Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ROU | FRA | ESP


No variant requirements are available.